Yıl: 2022 Cilt: 11 Sayı: 1 Sayfa Aralığı: 419 - 421 Metin Dili: İngilizce DOI: 10.5455/medscience.2021.08.260 İndeks Tarihi: 22-06-2022

Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia

Öz:
Familial hypercholesterolemia is a metabolic disease caused by a mutation in the low-density lipoprotein receptor gene. It carries early atherosclerosis and coronary artery disease risks. Coronary artery disease has been reported 20 times in the pediatric population with familial hypercholesterolemia compared to the normal population. Early diagnosis and treatment may reduce morbidity and mortality. In this article, we present a 16-year-old patient, who followed up for 12 years due to hypercholesterolemia and applied to our hospital due to chest pain, shortness of breath, and palpitation. After a detailed evaluation, we detected critical left and right main coronary artery stenosis, and bypass surgery was performed by cardiovascular surgeons. Early diagnosis of children with familial hypercholesterolemia or patients who have a family history of hypercholesterolemia will allow treatment of the disease and prevention of the complications.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
0
0
0
  • 1. Kawasuji M, Sakakibara N, Takemura H, et al. Coronary artery bypass grafting in familial hypercholesterolemia. J Thorac Cardiovasc Surg. 1995;109:364-9.
  • 2. Goldberg AC, Hopkins PN, Toth PP, et al. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(Suppl 3):1-8.
  • 3. Liyanage KE, Burnett JR, Hooper AJ, et al. Familial hypercholesterolemia: Epidemiology, Neolithic origins and modern geographic distribution. Crit Rev Clin Lab Sci. 2011;48:1-18.
  • 4. Fahed AC, Nemer GM. Familial hypercholesterolemia: the lipids or the genes? NutrMetab (Lond). 2011;22;8:23.
  • 5. Hovingh GK, Davidson MH, Kastelein JJP, et al. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J. 2013;34:962-71.
  • 6. Descamps OS, Gilbeau JP, Leysen X, et al. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia. Eur J Clin Invest. 2001;31:958-65.
  • 7. Demetriou K, H'Maltezou E, Pi erides AM: Familial homozygous hypercholesterolemia: effective long-term treatment with cascade double filtration plasmapheresis. Blood Purif. 2001;19:308-13.
  • 8. Nemati MH. Coronary revascularization in a child with homozygous familial hypercholesterolemia. Interact Cardiovasc Thorac Surg. 2010;10:131-2.
  • 9. Al-Dairy A, Srour S, Hasan H, et al. Coronary artery bypass grafting in a 12-year-old girl with familial hypercholesterolemia. Clin Case Rep. 2021;9:e04229.
  • 10. Castilla Cabezas JA, Lopez-Cillero P, Jimenez J, et al: Role of orthotopic liver transplant in treatment of homozygous FH. Rev Esp Enterm Dig. 2000;92:601-8.
APA öncül m, Karakurt C, ELKIRAN O, Akinci A, erdil n (2022). Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. , 419 - 421. 10.5455/medscience.2021.08.260
Chicago öncül mehmet,Karakurt Cemsit,ELKIRAN OZLEM,Akinci Aysehan,erdil nevzat Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. (2022): 419 - 421. 10.5455/medscience.2021.08.260
MLA öncül mehmet,Karakurt Cemsit,ELKIRAN OZLEM,Akinci Aysehan,erdil nevzat Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. , 2022, ss.419 - 421. 10.5455/medscience.2021.08.260
AMA öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. . 2022; 419 - 421. 10.5455/medscience.2021.08.260
Vancouver öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. . 2022; 419 - 421. 10.5455/medscience.2021.08.260
IEEE öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n "Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia." , ss.419 - 421, 2022. 10.5455/medscience.2021.08.260
ISNAD öncül, mehmet vd. "Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia". (2022), 419-421. https://doi.org/10.5455/medscience.2021.08.260
APA öncül m, Karakurt C, ELKIRAN O, Akinci A, erdil n (2022). Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. Medicine Science, 11(1), 419 - 421. 10.5455/medscience.2021.08.260
Chicago öncül mehmet,Karakurt Cemsit,ELKIRAN OZLEM,Akinci Aysehan,erdil nevzat Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. Medicine Science 11, no.1 (2022): 419 - 421. 10.5455/medscience.2021.08.260
MLA öncül mehmet,Karakurt Cemsit,ELKIRAN OZLEM,Akinci Aysehan,erdil nevzat Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. Medicine Science, vol.11, no.1, 2022, ss.419 - 421. 10.5455/medscience.2021.08.260
AMA öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. Medicine Science. 2022; 11(1): 419 - 421. 10.5455/medscience.2021.08.260
Vancouver öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia. Medicine Science. 2022; 11(1): 419 - 421. 10.5455/medscience.2021.08.260
IEEE öncül m,Karakurt C,ELKIRAN O,Akinci A,erdil n "Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia." Medicine Science, 11, ss.419 - 421, 2022. 10.5455/medscience.2021.08.260
ISNAD öncül, mehmet vd. "Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia". Medicine Science 11/1 (2022), 419-421. https://doi.org/10.5455/medscience.2021.08.260